Inflammation and oxidative stress are thought to play animportant role in the pathophysiology of heart failure with preserved ejectionfraction (HFpEF) through the development of endothelial dysfunction.Myeloperoxidase (MPO) functions as a link between oxidative stress andinflammation and is an interesting therapeutic target. This evidence concerns the gene MPO and endothelial dysfunction.